FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.3  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely cefprozil 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flupentixol 3 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely apraclonidine (as apraclonidine hydrochloride) 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely praziquantel 600 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cimetidine 400 milligram/1 each conventional release effervescent oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zinc sulfate 2.5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nitrofurantoin 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely urea 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely secobarbital sodium 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely colestipol hydrochloride 1 gram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amiodarone hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely megestrol acetate 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amorolfine (as amorolfine hydrochloride) 2.5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely losartan potassium 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely carisoprodol 125 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely imidapril hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely chloramphenicol 10 milligram/1 gram conventional release eye ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lornoxicam 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely donepezil hydrochloride 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely folic acid 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely itraconazole 100 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous foam Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tizanidine (as tizanidine hydrochloride) 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zinc (as zinc acetate) 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zonisamide 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flurbiprofen 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely streptomycin (as streptomycin sulfate) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pomalidomide 2 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyproterone acetate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely valsartan 160 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely phenytoin sodium 300 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely oxprenolol hydrochloride 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely valsartan 40 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ursodeoxycholic acid 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mercaptamine (as mercaptamine bitartrate) 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely imiglucerase 400 unit/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely gliquidone 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely eprosartan (as eprosartan mesilate) 600 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tolterodine tartrate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely balsalazide disodium 750 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thiamine hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flucloxacillin 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely levomepromazine maleate 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ofloxacin 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely orlistat 120 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tetrabenazine 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lenalidomide 5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely idarubicin hydrochloride 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely rofecoxib 2.5 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diloxanide furoate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely entecavir 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bisoprolol fumarate 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely oxygen 1 milliliter/1 milliliter conventional release gas for inhalation Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely loxapine 10 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely retigabine 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nicorandil 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flurbiprofen 100 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thioridazine hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely raltegravir 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely levofloxacin 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 100 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 3 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 50 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nateglinide 180 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lacidipine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely perphenazine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely buspirone 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine hydrochloride 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 254 of 342 Next End

    This concept is not in any reference sets

    Back to Start